Covid-19: Modernaapplies for US and EUapproval as vaccinetrial reports 94.1%efficacy Elisabeth Mahase2020 год

Covid-19: Moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy
статья из журнала